DOI QR코드

DOI QR Code

Erlotinib-Related Spontaneous Pneumothorax in Patient with Primary Lung Cancer

  • Nam, Hae-Seong (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine) ;
  • Lee, Hyeon-Jeong (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine) ;
  • Kim, Min-Su (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine) ;
  • Park, Sung-Wook (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine) ;
  • Jeon, Sang-Hoon (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine) ;
  • Cho, Jae-Hwa (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine) ;
  • Kwak, Seung-Min (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine) ;
  • Lee, Hong-Lyeol (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine) ;
  • Ryu, Jeong-Seon (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine)
  • 투고 : 2010.08.12
  • 심사 : 2010.10.01
  • 발행 : 2010.12.30

초록

Spontaneous pneumothorax (SPTx) associated with primary lung cancer is quite rare, but has been reported as the initial presentation or a complication of disease progression. Moreover, chemotherapy-related SPTx in primary lung cancer occurs at a very low frequency, accounting for less than 0.05% of all cases. Here, we report the first case of erlotinib-related SPTx in a patient with advanced lung adenocarcinoma in Korea. After 3 cycles of cisplatin-based chemotherapy as first-line therapy, erlotinib was administered as second-line treatment. Asymptomatic SPTx accompanied by a significant decrease in tumor size was observed in the left lung 7 weeks later. The patient received continuous administration of erlotinib, without additional treatment. This case showed that SPTx can occur in patients with primary lung cancer receiving erlotinib, and asymptomatic chemotherapy-related SPTx in primary lung cancer may not require therapeutic intervention.

키워드

참고문헌

  1. Steinhauslin CA, Cuttat JF. Spontaneous pneumothorax: a complication of lung cancer? Chest 1985;88:709-13. https://doi.org/10.1378/chest.88.5.709
  2. Lai RS, Perng RP, Chang SC. Primary lung cancer complicated with pneumothorax. Jpn J Clin Oncol 1992; 22:194-7.
  3. O'Connor BM, Ziegler P, Spaulding MB. Spontaneous pneumothorax in small cell lung cancer. Chest 1992; 102:628-9. https://doi.org/10.1378/chest.102.2.628
  4. Mori M, Nakagawa M, Fujikawa T, Iwasaki T, Kawamura T, Namba Y, et al. Simultaneous bilateral spontaneous pneumothorax observed during the administration of gefitinib for lung adenocarcinoma with multiple lung metastases. Intern Med 2005;44:862-4. https://doi.org/10.2169/internalmedicine.44.862
  5. Dines DE, Cortese DA, Brennan MD, Hahn RG, Payne WS. Malignant pulmonary neoplasms predisposing to spontaneous pneumothorax. Mayo Clin Proc 1973;48: 541-4.
  6. Biran H, Dgani R, Wasserman JP, Weissberg D, Shani A. Pneumothorax following induction chemotherapy in patients with lung metastases: a case report and literature review. Ann Oncol 1992;3:297-300. https://doi.org/10.1093/oxfordjournals.annonc.a058183
  7. Fenlon HM, Carney D, Breatnach E. Case report: bilateral recurrent tension pneumothorax complicating combination chemotherapy for soft tissue sarcoma. Clin Radiol 1996;51:302-4. https://doi.org/10.1016/S0009-9260(96)80353-9
  8. Stein ME, Shklar Z, Drumea K, Goralnik L, Ben-Arieh Y, Haim N. Chemotherapy-induced spontaneous pneumothorax in a patient with bulky mediastinal lymphoma: a rare oncologic emergency. Oncology 1997;54: 15-8.
  9. Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J, et al. Erlotinib in lung cancer - molecular and clinical predictors of outcome. N Engl J Med 2005;353:133-44. https://doi.org/10.1056/NEJMoa050736
  10. Moyer JD, Barbacci EG, Iwata KK, Arnold L, Boman B, Cunningham A, et al. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res 1997;57:4838-48.